Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis.
Rajwa P, Yanagisawa T, Heidegger I, Zattoni F, Marra G, Soeterik TFW, van den Bergh RCN, Valerio M, Ceci F, Kesch CV, Kasivisvanathan V, Laukhtina E, Kawada T, Nyiriadi P, Trinh QD, Chlosta P, Karakiewicz PI, Ploussard G, Briganti A, Montorsi F, Shariat SF, Gandaglia G; EAU-YAU Prostate Cancer Working Party. Rajwa P, et al. Among authors: yanagisawa t. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):170-179. doi: 10.1038/s41391-022-00607-5. Epub 2022 Oct 25. Prostate Cancer Prostatic Dis. 2023. PMID: 36284192
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer.
Yanagisawa T, Kimura T, Mori K, Suzuki H, Sano T, Otsuka T, Iwamoto Y, Fukuokaya W, Miyajima K, Enei Y, Sakanaka K, Matsukawa A, Onuma H, Obayashi K, Tsuzuki S, Hata K, Shimomura T, Miki J, Egawa S. Yanagisawa T, et al. Prostate. 2022 Jan;82(1):3-12. doi: 10.1002/pros.24243. Epub 2021 Sep 24. Prostate. 2022. PMID: 34559410
Comparison of Clinicopathologic and Oncological Outcomes Between Transurethral En Bloc Resection and Conventional Transurethral Resection of Bladder Tumor: A Systematic Review, Meta-Analysis, and Network Meta-Analysis with Focus on Different Energy Sources.
Sari Motlagh R, Rajwa P, Mori K, Laukhtina E, Aydh A, Katayama S, Yanagisawa T, König F, Grossmann NC, Pradere B, Mostafai H, Quhal F, Karakiewicz PI, Babjuk M, Shariat SF. Sari Motlagh R, et al. Among authors: yanagisawa t. J Endourol. 2022 Apr;36(4):535-547. doi: 10.1089/end.2021.0688. Epub 2021 Nov 16. J Endourol. 2022. PMID: 34693740
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.
Yanagisawa T, Mori K, Katayama S, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Motlagh RS, Aydh A, König F, Grossmann NC, Pradere B, Miki J, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Int J Clin Oncol. 2022 Jan;27(1):59-71. doi: 10.1007/s10147-021-02061-0. Epub 2021 Nov 10. Int J Clin Oncol. 2022. PMID: 34757531 Free PMC article. Review.
Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy.
Rajwa P, Huebner NA, Hostermann DI, Grossmann NC, Schuettfort VM, Korn S, Quhal F, König F, Mostafaei H, Laukhtina E, Mori K, Motlagh RS, Yanagisawa T, Aydh A, Bryniarski P, Pradere B, Paradysz A, Baltzer PA, Grubmüller B, Shariat SF. Rajwa P, et al. Among authors: yanagisawa t. J Pers Med. 2021 Nov 19;11(11):1231. doi: 10.3390/jpm11111231. J Pers Med. 2021. PMID: 34834583 Free PMC article.
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes.
Laukhtina E, Sari Motlagh R, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF. Laukhtina E, et al. Among authors: yanagisawa t. Crit Rev Oncol Hematol. 2022 Jan;169:103570. doi: 10.1016/j.critrevonc.2021.103570. Epub 2021 Dec 10. Crit Rev Oncol Hematol. 2022. PMID: 34902554 Free article. Review.
Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis.
Katayama S, Mori K, Pradere B, Yanagisawa T, Mostafaei H, Quhal F, Motlagh RS, Laukhtina E, Grossmann NC, Rajwa P, Aydh A, König F, Karakiewicz PI, Araki M, Nasu Y, Shariat SF. Katayama S, et al. Among authors: yanagisawa t. J Robot Surg. 2022 Dec;16(6):1233-1247. doi: 10.1007/s11701-021-01361-x. Epub 2021 Dec 31. J Robot Surg. 2022. PMID: 34972981 Free PMC article. Review.
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy.
Laukhtina E, Quhal F, Mori K, Sari Motlagh R, Rajwa P, Yanagisawa T, Mostafaei H, König F, Aydh A, Pradere B, Enikeev D, Karakiewicz PI, Schmidinger M, Shariat SF. Laukhtina E, et al. Among authors: yanagisawa t. Eur Urol Oncol. 2022 Feb;5(1):120-124. doi: 10.1016/j.euo.2021.12.007. Epub 2022 Jan 3. Eur Urol Oncol. 2022. PMID: 34992006
En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology.
Yanagisawa T, Mori K, Motlagh RS, Kawada T, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Aydh A, König F, Pallauf M, Pradere B, D'Andrea D, Compérat E, Miki J, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. J Urol. 2022 Apr;207(4):754-768. doi: 10.1097/JU.0000000000002444. Epub 2022 Jan 21. J Urol. 2022. PMID: 35060770
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis.
Mori K, Schuettfort VM, Yanagisawa T, Katayama S, Pradere B, Laukhtina E, Rajwa P, Mostafaei H, Sari Motlagh R, Quhal F, Moschini M, Soria F, Teoh JYC, D'Andrea D, Abufaraj M, Albisinni S, Krajewski W, Egawa S, Karakiewicz PI, Rink M, Shariat SF; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Mori K, et al. Among authors: yanagisawa t. Eur Urol Focus. 2022 Nov;8(6):1687-1695. doi: 10.1016/j.euf.2022.02.007. Epub 2022 Mar 9. Eur Urol Focus. 2022. PMID: 35279408 Free article. Review.
1,144 results